$WORX
SCWorx Corp.

2023 Q2 Form 10-Q Financial Statement

#000121390023039696 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $991.1K $997.4K $1.031M
YoY Change -0.13% -3.25% -10.35%
Cost Of Revenue $616.0K $689.5K $697.6K
YoY Change -1.21% -1.17% 1.11%
Gross Profit $375.1K $308.0K $333.3K
YoY Change 1.68% -7.6% -25.93%
Gross Profit Margin 37.84% 30.88% 32.33%
Selling, General & Admin $523.5K $707.9K $1.099M
YoY Change -43.84% -35.62% -8.38%
% of Gross Profit 139.58% 229.84% 329.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $523.5K $707.9K $1.099M
YoY Change -66.35% -35.62% -9.14%
Operating Profit -$148.5K -$399.9K -$766.1K
YoY Change -73.65% -47.81% 0.81%
Interest Expense $5.459K
YoY Change -83.34%
% of Operating Profit
Other Income/Expense, Net -$5.459K $139.6K
YoY Change
Pretax Income -$153.9K -$399.9K -$626.6K
YoY Change -72.68% -36.18% -16.46%
Income Tax
% Of Pretax Income
Net Earnings -$153.9K -$399.9K -$626.6K
YoY Change -72.68% -36.18% -16.46%
Net Earnings / Revenue -15.53% -40.09% -60.77%
Basic Earnings Per Share -$0.01 -$0.03 -$0.06
Diluted Earnings Per Share -$0.01 -$0.03 -$55.28K
COMMON SHARES
Basic Shares Outstanding 13.02M shares 13.02M shares 11.38M shares
Diluted Shares Outstanding 13.82M shares 13.02M shares 11.33M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $133.0K $249.7K $8.290K
YoY Change 466.33% 2912.3% -90.79%
Cash & Equivalents $133.0K $249.7K $8.293K
Short-Term Investments
Other Short-Term Assets $90.53K $316.0K $119.6K
YoY Change -72.39% 164.35% -8.04%
Inventory $156.6K
Prepaid Expenses
Receivables $458.8K $344.4K $697.2K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $682.4K $910.2K $981.6K
YoY Change -2.31% -7.28% -55.98%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change
Goodwill $8.366M $8.366M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $8.366M $8.366M $8.366M
YoY Change 0.0% 0.0% -0.16%
TOTAL ASSETS
Total Short-Term Assets $682.4K $910.2K $981.6K
Total Long-Term Assets $8.366M $8.366M $8.366M
Total Assets $9.049M $9.277M $9.348M
YoY Change -0.18% -0.76% -11.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.8K $1.854M
YoY Change -91.7% -0.88%
Accrued Expenses $1.391M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.340M $2.624M $2.843M
YoY Change -10.86% -7.72% -35.97%
LONG-TERM LIABILITIES
Long-Term Debt $114.3K $128.7K $294.0K
YoY Change -61.12% -56.23% -31.63%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $114.3K $128.7K $294.0K
YoY Change -61.12% -56.23% -31.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.340M $2.624M $2.843M
Total Long-Term Liabilities $114.3K $128.7K $294.0K
Total Liabilities $2.455M $2.752M $3.137M
YoY Change -15.92% -12.27% -35.58%
SHAREHOLDERS EQUITY
Retained Earnings -$26.41M -$26.26M
YoY Change 4.81%
Common Stock $16.16K $13.02K
YoY Change 37.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.594M $6.525M $6.211M
YoY Change
Total Liabilities & Shareholders Equity $9.049M $9.277M $9.348M
YoY Change -0.18% -0.76% -11.89%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$153.9K -$399.9K -$626.6K
YoY Change -72.68% -36.18% -16.46%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$347.8K $19.35K -$62.78K
YoY Change -2388.36% -130.82% -85.4%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 231.1K -$19.09K
YoY Change
NET CHANGE
Cash From Operating Activities -347.8K $19.35K -62.78K
Cash From Investing Activities 0.000
Cash From Financing Activities 231.1K -$19.09K
Net Change In Cash -116.7K $256.00 $0.00
YoY Change -867.7%
FREE CASH FLOW
Cash From Operating Activities -$347.8K $19.35K -$62.78K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Gain Loss On Sales Of Consumer Loans
GainLossOnSalesOfConsumerLoans
usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11334905 shares
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37899
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5412331
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
590 Madison Avenue
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
21st Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2023Q1 dei City Area Code
CityAreaCode
(844)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
472-9679
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
WORX
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13021741 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249718 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249462 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
344449 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336033 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
316033 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
295180 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
910200 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
880675 usd
CY2023Q1 us-gaap Goodwill
Goodwill
8366467 usd
CY2022Q4 us-gaap Goodwill
Goodwill
8366467 usd
CY2023Q1 us-gaap Assets
Assets
9276667 usd
CY2022Q4 us-gaap Assets
Assets
9247142 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1509334 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1364202 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
153838 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
153838 usd
CY2023Q1 worx Shareholder Advance
ShareholderAdvance
100000 usd
CY2022Q4 worx Shareholder Advance
ShareholderAdvance
100000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
735333 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
579833 usd
CY2023Q1 worx Equity Financing Current
EquityFinancingCurrent
125000 usd
CY2022Q4 worx Equity Financing Current
EquityFinancingCurrent
125000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2623505 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2322873 usd
CY2023Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
128659 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
147749 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
128659 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
147749 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2752164 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2470622 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
40 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
40 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13021741 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13021741 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13010409 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13010409 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
13022 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
13011 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32170028 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32022166 usd
CY2023Q1 worx Subscriptions Payable
SubscriptionsPayable
600000 usd
CY2022Q4 worx Subscriptions Payable
SubscriptionsPayable
600000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26258587 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25858697 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6524503 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6776520 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9276667 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9247142 usd
CY2023Q1 us-gaap Revenues
Revenues
997449 usd
CY2022Q1 us-gaap Revenues
Revenues
1030949 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
689462 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
697636 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
707877 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1099454 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1397339 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1797090 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-399890 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-766141 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Consumer Loans
GainLossOnSalesOfConsumerLoans
139595 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139595 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-399890 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-626546 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-399890 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-626546 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13019127 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11334905 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6776520 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
147873 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-399890 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6524503 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6405070 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
85000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
347568 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-626546 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6211092 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-399890 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-626546 usd
CY2022Q1 worx Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
139595 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
147873 usd
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
347568 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46875 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8416 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
279219 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20853 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
55611 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
145132 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
351996 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
155500 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
291750 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19346 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62782 usd
CY2023Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
19090 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19090 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
256 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62782 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249462 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71075 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249718 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8293 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
473 usd
CY2022Q1 worx Shares Issued For Equity Financings
SharesIssuedForEquityFinancings
250000 usd
CY2023Q1 worx Shares Issued For Vested Restricted Stock Units
SharesIssuedForVestedRestrictedStockUnits
11 usd
CY2022Q1 worx Shares Issued For Vested Restricted Stock Units
SharesIssuedForVestedRestrictedStockUnits
19 usd
CY2023Q1 worx Acquired Technology Predecessor Cost
AcquiredTechnologyPredecessorCost
0 usd
CY2023Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
250000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit and Other Risks</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, accounts receivable and warrants. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing internal credit evaluations of its customers’ financial condition, obtains deposits and limits the amount of credit extended when deemed necessary but generally requires no collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant customers are those which represent more than 10% of the Company’s revenue for each period presented, or the Company’s accounts receivable balance as of each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total net accounts receivable are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Revenue For the</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center"> three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Accounts Receivable</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Customers</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">55</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.10 pure
CY2023Q1 worx Gowns In Inventory
GownsInInventory
87000 usd
CY2021Q4 us-gaap Other Inventory
OtherInventory
366840 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
523440 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
523440 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
523440 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
523440 usd
CY2023Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
735333 usd
CY2022 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
579833 usd
CY2023Q1 worx Contract Liabilities
ContractLiabilities
735333 usd
CY2022Q4 worx Contract Liabilities
ContractLiabilities
579833 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to the allowance for doubtful accounts, the estimated useful lives and recoverability of long-lived assets, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Actual results could differ materially from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2020Q2 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.60 pure
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.01 pure
CY2020Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P2Y
CY2022Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-03-05
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
139569 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
0 usd
CY2022 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
0 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
435 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
487 usd
CY2023Q1 worx Total Leases Cost
TotalLeasesCost
435 usd
CY2022Q1 worx Total Leases Cost
TotalLeasesCost
487 usd
CY2023Q1 us-gaap Loss Contingency Actions Taken By Plaintiff
LossContingencyActionsTakenByPlaintiff
Under the terms of this agreement, (i) the insurers for the Company and Marc Schessel (former CEO) will make a cash payment to the class plaintiffs (ii) the former CEO will transfer 100,000 shares of company common stock to the class plaintiffs, and (iii) the Company will issue $600,000 worth of common stock to the class plaintiffs, in exchange for which all parties will be released from all claims related to the securities class action litigation. After giving effect to the share issuance by the Company, the Company believes that it will have satisfied the accrued retention liability of $700,000.
CY2022Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
190000 usd
CY2023Q1 us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
257545.63 usd
CY2023Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
500000 usd
CY2022Q2 us-gaap Loss Contingency Settlement Agreement Terms
LossContingencySettlementAgreementTerms
the Company reached a settlement in principle with the SEC Staff which, subject to a few changes, was subsequently approved by the Commission in which the Company agreed to resolve the SEC’s investigation regarding the April 13, 2020 press release and related disclosures (related to Covid-19 rapid test kits) through the Company’s payment of (a) a civil monetary penalty of $125,000, payable in 4 equal installments over 12 months and (b) disgorgement of $471,000 and prejudgment interest in the amount of $32,761.56 which payment is to be deemed satisfied by the transfer by the Company, no later than 30 days after the entry of the Class Distribution Order in the class action entitled Yannes v. SCWorx Corp. of shares of SCWorx’s common stock, valued at $600,000 at the time of issuance to authorized claimants in the Yannes settlement, provided that the Class Distribution Order is entered within 365 days from the entry of the Final Judgment in the SEC action. In the event that the Company does not transfer shares of its common stock, valued at $600,000 at the time of issuance to authorized claimants in the class action settlement within 365 days from the entry of a Final Judgment, the Company will be required to remit to the SEC the full amount of disgorgement within 395 days from entry of a Final Judgment.
CY2022Q2 us-gaap Income Tax Examination Penalties Accrued
IncomeTaxExaminationPenaltiesAccrued
125000 usd
CY2023Q1 worx Share Based Compensation Arrangement By Share Based Payment Award Options Vested Restricted Units
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedRestrictedUnits
11332 shares
CY2020Q2 worx Received Amount
ReceivedAmount
515000 usd
CY2020Q2 us-gaap Financing Receivable Sale
FinancingReceivableSale
565000 usd
CY2020Q2 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
135527 shares
CY2020Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.8
CY2020Q2 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
169409 shares
CY2020Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
4
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
415000 usd
CY2023Q1 worx Equity Financing
EquityFinancing
125000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
259000 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
222000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
147873 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
347568 usd
CY2023Q1 worx Share Based Compensation Common Stock
ShareBasedCompensationCommonStock
147873 usd
CY2022Q1 worx Share Based Compensation Common Stock
ShareBasedCompensationCommonStock
347568 usd
CY2023Q1 worx Share Based Compensation Total
ShareBasedCompensationTotal
147873 usd
CY2022Q1 worx Share Based Compensation Total
ShareBasedCompensationTotal
347568 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4402847 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3664004 shares
CY2023Q1 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
153838 usd
CY2022Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
153838 usd
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
100000 usd
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SCWorx Corp.
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13019127 shares
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q1 worx Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 worx Shares Issued For Equity Financings
SharesIssuedForEquityFinancings
usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001674227

Files In Submission

Name View Source Status
0001213900-23-039696-index-headers.html Edgar Link pending
0001213900-23-039696-index.html Edgar Link pending
0001213900-23-039696.txt Edgar Link pending
0001213900-23-039696-xbrl.zip Edgar Link pending
f10q0323ex31-1_scworx.htm Edgar Link pending
f10q0323ex31-2_scworx.htm Edgar Link pending
f10q0323ex32-1_scworx.htm Edgar Link pending
f10q0323ex32-2_scworx.htm Edgar Link pending
f10q0323_scworx.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
f10q0323_scworx_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
worx-20230331.xsd Edgar Link pending
worx-20230331_def.xml Edgar Link unprocessable
worx-20230331_lab.xml Edgar Link unprocessable
worx-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
worx-20230331_cal.xml Edgar Link unprocessable